FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/105832 [Registered on: 10/03/2026] Trial Registered Prospectively
Last Modified On: 10/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Study to Evaluate the Effect of Jyotishmatyadi Yoga Vati in Women having Reduced Menstrual Flow 
Scientific Title of Study   An Exploratory Clinical Study To Evalute Effect Of Jyotishmatyadi Yoga Vati In The Management Of Artava Kshaya (Hypomenorrhea) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Bhuvneshwari Sharma 
Designation  P.G. Scholar 
Affiliation  Post Graduate Institute of Ayurved Dr S R Rajasthan Ayurved University Jodhpur  
Address  PG dept of Stree roga Prasuti Tantra Post Graduate Institute of Ayurveda Dr S R Rajasthan Ayurved University Jodhpur Rajasthan 342037 India

Jodhpur
RAJASTHAN
342037
India 
Phone  8619487967  
Fax    
Email  yeahitsbhuvi@gmail.com  
 
Details of Contact Person
Scientific Query  
Name  Dr A Neelima  
Designation  Professor & HOD 
Affiliation  Post Graduate Institute of Ayurved Dr S R Rajasthan Ayurved University Jodhpur  
Address  Department of Stree Roga-Prasuti Tantra Post Graduate Institute of Ayurveda Opd No 5 Dr S R Rajasthan Ayurved University Jodhpur Rajasthan 342037 India

Jodhpur
RAJASTHAN
342037
India 
Phone  9610350131  
Fax    
Email  aspneelima@gmail.com  
 
Details of Contact Person
Public Query  
Name  Dr Bhuvneshwari Sharma 
Designation  P.G. Scholar 
Affiliation  Post Graduate Institute of Ayurved Dr S R Rajasthan Ayurved University Jodhpur  
Address  Department of Stree Roga-Prasuti Tantra Post Graduate Institute of Ayurveda Opd No 5 Dr S R Rajasthan Ayurved University Jodhpur Rajasthan 342037 India

Jodhpur
RAJASTHAN
342037
India 
Phone  8619487967  
Fax    
Email  yeahitsbhuvi@gmail.com  
 
Source of Monetary or Material Support  
Post Graduate Institute of Ayurved Jodhpur Rajasthan India 342037 
 
Primary Sponsor  
Name  Post Graduate Institute of Ayurved Jodhpur Rajasthan India 342037 
Address  PG Dept of Stree Roga Prasuti Tantra Post Graduate Institute of Ayurved Dr S R Rajasthan Ayurved University Jodhpur Rajasthan India 342037 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
Dr Bhuvneshwari Sharma   PG Dept of Stree Roga Prasuti Tantra Post Graduate Institute of Ayurved Dr S R Rajasthan Ayurved University Jodhpur Rajasthan India 342037 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Bhuvneshwari Sharma  Post Graduate Institute of Ayurveda Jodhpur Rajasthan   Post Graduate Institute of Ayurveda Dr S R Rajasthan Ayurved University Jodhpur Rajasthan 342037 India
Jodhpur
RAJASTHAN 		 8619487967

yeahitsbhuvi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Commitee Post Graduate Institute of Ayurved   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N915||Oligomenorrhea, unspecified. Ayurveda Condition: ARTAVAKSHAYAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: JYOTISHMATYADI YOGA VATI, Reference: Bhavprakash madhya khanda, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: -Milk), Additional Information: -
 
Inclusion Criteria  
Age From  17.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  Inclusion criteria -
1 Patients willing for the trial
2 Patient who has completed 3 years after menarche to 40 years of age.
3 Hypomenorrhea (scanty menses)- Score less than 10 on PBLAC 
 
ExclusionCriteria 
Details  Patient less than 3 years of menarche and more than 40 years of age.
1 Lactating women.
2 Patients with any reproductive system abnormalities like hydrosalpinx, fibroiduterus, carcinoma of reproductive organ and sexually transmitteddisease (STDs), Human Immunodeficiency Virus (HIV), Hepatitis B Surface Antigen (HBsAg).
3 Systemic disorders like-uncontrolled diabetes mellitus, chronic liver disease, renal disorder, Uncontrolled hypertension, Diagnosed case of any type of malignancy 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To reduce Artava Kshaya.  2 months  
 
Secondary Outcome  
Outcome  TimePoints 
Secondary outcome: Relief in abdominal pain, duration and interval  2 months 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/05/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Summary:This is an open label single arm exploratory interventional study enrolling thirty patients diagnosed with Artava Kshaya or Hypomenorrhea. The study design is interventional non randomized open label single arm with no comparator or placebo. Participants will receive Jyotishmatyadi Yoga Vati at a dose of five hundred milligrams per tablet two tablets twice daily with milk. The primary objective is to assess improvement in menstrual flow and cycle regularity. The secondary objective is to evaluate symptom relief and safety. The outcomes include menstrual blood volume cycle pattern symptom changes and safety profile.


    •  
    Close